跳至主要内容
临床试验/NCT02729012
NCT02729012已完成4 期

Effects of Hypertonic Saline Solution (NACL 3%+NAHCO3) on Nasal Inflammation in Children With Allergic Rhinitis. RinASol- Pilot Study (Allergic Rhinitis Solution)

Stefania La Grutta, MD1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2015年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
Symptom score assessment

研究概览

简要总结

The main objective of RinASol project is to assess in patients with seasonal Allergic Rhinitis the effect of hypertonic saline solution NACL 3%+NAHCO3 vs the effect of standard saline solution on nasal inflammation by means of nasal cytology.

The secondary objective is the symptom score assessment by T5SS Questionnaire (Total Symptom Score 5)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
6 Years 至 14 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Clinical history of Allergic Rhinitis (for at least 1 year)
  • 6 years old ≤ children age ≤ 14 years old
  • Total Symptom Score 5: >5 in the last 4 days before screening. Exclusion Criteria
  • Signs of acute infections of upper and lower respiratory tract.
  • Metabolic, immunological, systemic diseases
  • Respiratory tract deformity
  • Systemic/Topical therapies with antibiotics or corticosteroids in the previous 30 days.
  • Active smoker.

排除标准

  • 未提供

研究组 & 干预措施

Case

Active Comparator

Allergic Rhinitis Children treated with hypertonic saline solution (NACL 3%+NAHCO3)

干预措施: hypertonic saline solution (NACL 3%+NAHCO3) (Drug)

Control

Placebo Comparator

Allergic Rhinitis Children treated with saline solution (NACL 0,9%)

干预措施: Saline Solution (NACL 0,9%) (Other)

结局指标

主要结局

Symptom score assessment

时间窗: 28 days

The main objective is to evaluate the effect of hypertonic saline solution NACL 3%+NAHCO3 vs the effect of standard saline solution on the symptom score assessed by T5SS Questionnaire (Total Symptom Score 5)

次要结局

  • Nasal cytology pattern(28 days)

研究者

发起方
Stefania La Grutta, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Stefania La Grutta, MD

Stefania La Grutta, MD. Senior Researcher. Coordinator of Pediatric Allergy and Asthma Research Group. Institute of Biomedicine and Molecular Immunology, IBIM, National Research Council of Palermo, Italy.

Istituto per la Ricerca e l'Innovazione Biomedica

研究点 (1)

Loading locations...

相似试验